Funder: National Institutes of Health
Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (final application deadline)
Funding Amounts: Direct costs up to $150,000 per year, for up to 2 years; estimated total program funding $150,000; ~3 awards expected
Summary: Supports revision applications from active NCI P50 specialized centers to integrate and validate novel technologies developed through the NCI IMAT program, accelerating cancer research.
Key Information: Only current NCI P50 awardees with at least one year remaining on their parent grant are eligible.